Related Experiment Video
Updated: May 31, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy in the cardiorenal syndrome
Margot K Davis1, Sean A Virani
1Division of Cardiology, Gordon and Leslie Diamond Health Care Centre, The University of British Columbia, Vancouver, BC, Canada V5Z 1M9.
Abstract:
The cardiorenal syndrome (CRS) is a complex clinical syndrome in which dysfunction of either the heart or the kidneys affects the functioning of the other organ system. Many therapies used in heart failure have further detrimental effects on renal function. Cardiac resynchronization therapy (CRT) is a relatively new form of device therapy that reduces morbidity and mortality in patients with heart failure. This review will discuss the effects of CRT on renal function in patients with CRS, the impact of baseline renal function on response to CRT, and potential risks associated with CRT in this unique population.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Continuous Renal Replacement Therapy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
